Picture of Emergent BioSolutions logo

EBS — Emergent BioSolutions News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Brief: Enrollment Starts in Africa CDC-Led MpOx Therapeutic Study (MOSA)

Jan 16 (Reuters) - 
  
    * ENROLLMENT STARTS IN AFRICA CDC-LED MPOX THERAPEUTIC STUDY
(MOSA)
    * EMERGENT BIOSOLUTIONS INC - FIRST INTERIM ANALYSIS OF MOSA
TRIAL
EXPECTED BY END OF Q1 2025

Source text:  ID:nGNX8qjhCT 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Emergent BioSolutions

See all news